Benralizumab Side Effects

Side effects not requiring immediate medical attention.

Benralizumab side effects.

If you experience any of these symptoms or those in the special precautions section call your doctor immediately or get emergency medical treatment. Do not use fasenra if you are allergic to benralizumab or any of the ingredients in fasenra. Common side effects may include. Serious allergic reactions can happen after you get your fasenra injection.

If this effect lasts or gets worse tell your doctor or pharmacist promptly. Allergic hypersensitivity reactions including anaphylaxis. Do not use to treat sudden breathing problems. See also how to use section.

Difficult breathing feeling light headed. Allergic hypersensitivity reactions including anaphylaxis. Do not use fasenra if you are allergic to benralizumab or any of the ingredients in fasenra. Fasenra benralizumab is a brand name drug used for severe eosinophilic asthma.

Swelling of your face lips tongue or throat. Also your health care professional may be able to tell you about ways to prevent or reduce some of these side effects. Fasenra benralizumab injection is an interleukin 5 receptor alpha directed cytolytic monoclonal antibody igg1 kappa indicated for the add on maintenance treatment of patients with severe asthma aged 12 years and older and with an eosinophilic phenotype common side effects of fasenra include. Call your doctor at once if you have.

New or worsening asthma symptoms. Do not use to treat sudden breathing problems. Fever hypersensitivity reactions and. Learn about side effects dosage alternatives and more.

Some side effects of benralizumab may occur that usually do not need medical attention. It comes as a syringe and an autoinjector pen. Benralizumab injection may cause side effects. Tell your doctor if any of these symptoms are severe or do not go away.

Serious allergic reactions can happen after you get your fasenra injection. Remember that your doctor has prescribed this. Fasenra may cause serious side effects including. Benralizumab fasenra as an add on therapy is recommended as an option for treating severe eosinophilic asthma that is inadequately controlled in adults despite maintenance therapy with high dose inhaled corticosteroids and long acting beta agonists only if the patient has agreed to and followed the optimised standard treatment plan and the blood eosinophil count has been recorded as.

These side effects may go away during treatment as your body adjusts to the medicine. Fasenra may cause serious side effects including. If benralizumab is transferred into human milk the effects of local exposure in the gastrointestinal tract and potential limited systemic exposure in the infant to benralizumab are unknown.